AVITA Medical, Inc. (RCEL)
USD 7.35
(-2.2%)
USD 7.35
(-2.2%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 19.86 Million USD | 0.0% |
| 2020 | 10.06 Million USD | -30.99% |
| 2019 | 14.57 Million USD | 0.0% |
| 2017 | 4.01 Million USD | 57.68% |
| 2016 | 2.54 Million USD | 45.46% |
| 2015 | 1.75 Million USD | 42.74% |
| 2014 | 1.22 Million USD | -31.35% |
| 2013 | 1.78 Million USD | -27.19% |
| 2012 | 2.45 Million USD | 14.0% |
| 2011 | 2.15 Million USD | 26.54% |
| 2010 | 1.7 Million USD | -56.17% |
| 2009 | 3.87 Million USD | 287.84% |
| 2008 | 1 Million USD | -60.72% |
| 2007 | 2.54 Million USD | 138.67% |
| 2006 | 1.06 Million USD | -44.69% |
| 2005 | 1.92 Million USD | 0.0% |
| 2003 | 511.26 Thousand USD | 63.12% |
| 2002 | 313.43 Thousand USD | -40.36% |
| 2001 | 525.57 Thousand USD | 1351.65% |
| 2000 | 36.2 Thousand USD | -58.71% |
| 1999 | 87.69 Thousand USD | 342.35% |
| 1998 | 19.82 Thousand USD | 4.35% |
| 1997 | 18.99 Thousand USD | -61.8% |
| 1996 | 49.73 Thousand USD | -41.9% |
| 1995 | 85.6 Thousand USD | -64.52% |
| 1994 | 241.24 Thousand USD | -36.85% |
| 1993 | 381.99 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q3 | 28.05 Million USD | 5.68% |
| 2023 Q2 | 26.54 Million USD | 17.85% |
| 2023 Q1 | 22.52 Million USD | 13.4% |
| 2022 Q2 | 14.64 Million USD | 26.29% |
| 2022 Q3 | 18.67 Million USD | 27.56% |
| 2022 FY | 19.86 Million USD | 0.0% |
| 2022 Q4 | 19.86 Million USD | 6.36% |
| 2022 Q1 | 11.59 Million USD | 0.0% |
| 2021 Q3 | 9.68 Million USD | -1.68% |
| 2021 Q1 | 12.03 Million USD | -4.39% |
| 2021 Q2 | 9.84 Million USD | -18.21% |
| 2020 Q4 | 12.59 Million USD | -9.23% |
| 2020 FY | 10.06 Million USD | -30.99% |
| 2020 Q2 | 14.57 Million USD | 0.0% |
| 2020 Q3 | 13.87 Million USD | -4.85% |
| 2019 FY | 14.57 Million USD | 0.0% |
| 2019 Q2 | 6.38 Million USD | 0.0% |
| 2019 Q4 | 12.22 Million USD | 0.0% |
| 2018 Q2 | 4.01 Million USD | 0.0% |
| 2018 Q4 | 5.1 Million USD | 0.0% |
| 2017 Q4 | 1.99 Million USD | 0.0% |
| 2017 Q2 | 2.54 Million USD | 0.0% |
| 2017 FY | 4.01 Million USD | 57.68% |
| 2016 Q2 | 1.75 Million USD | 0.0% |
| 2016 Q4 | 984.14 Thousand USD | 0.0% |
| 2016 FY | 2.54 Million USD | 45.46% |
| 2015 FY | 1.75 Million USD | 42.74% |
| 2015 Q2 | 1.22 Million USD | 0.0% |
| 2015 Q4 | 1.85 Million USD | 0.0% |
| 2014 Q2 | 1.78 Million USD | 0.0% |
| 2014 Q4 | 1.4 Million USD | 0.0% |
| 2014 FY | 1.22 Million USD | -31.35% |
| 2013 FY | 1.78 Million USD | -27.19% |
| 2013 Q4 | 1.59 Million USD | 0.0% |
| 2013 Q2 | 2.45 Million USD | 0.0% |
| 2012 Q2 | 2.15 Million USD | 0.0% |
| 2012 FY | 2.45 Million USD | 14.0% |
| 2012 Q4 | 1.65 Million USD | 0.0% |
| 2011 FY | 2.15 Million USD | 26.54% |
| 2011 Q2 | 1.53 Million USD | 0.0% |
| 2011 Q4 | 1.45 Million USD | 0.0% |
| 2010 FY | 1.7 Million USD | -56.17% |
| 2010 Q2 | 3.87 Million USD | 0.0% |
| 2010 Q4 | 3.41 Million USD | 0.0% |
| 2009 Q4 | 802.3 Thousand USD | 0.0% |
| 2009 FY | 3.87 Million USD | 287.84% |
| 2009 Q2 | 1 Million USD | 0.0% |
| 2008 Q4 | 1.38 Million USD | 0.0% |
| 2008 Q2 | 2.54 Million USD | 0.0% |
| 2008 FY | 1 Million USD | -60.72% |
| 2007 Q4 | 1.13 Million USD | 0.0% |
| 2007 Q2 | 1.06 Million USD | 0.0% |
| 2007 FY | 2.54 Million USD | 138.67% |
| 2006 FY | 1.06 Million USD | -44.69% |
| 2006 Q2 | 1.92 Million USD | 0.0% |
| 2006 Q4 | 1.21 Million USD | 0.0% |
| 2005 Q4 | 1.14 Million USD | 0.0% |
| 2005 FY | 1.92 Million USD | 0.0% |
| 2004 Q2 | 511.26 Thousand USD | 0.0% |
| 2004 Q4 | 1.06 Million USD | 0.0% |
| 2003 Q4 | 662.43 Thousand USD | 0.0% |
| 2003 FY | 511.26 Thousand USD | 63.12% |
| 2002 Q4 | 313.43 Thousand USD | 0.0% |
| 2002 FY | 313.43 Thousand USD | -40.36% |
| 2001 Q4 | 524.08 Thousand USD | 0.0% |
| 2001 FY | 525.57 Thousand USD | 1351.65% |
| 2000 Q4 | 36.46 Thousand USD | 0.0% |
| 2000 FY | 36.2 Thousand USD | -58.71% |
| 1999 Q4 | 87.69 Thousand USD | 0.0% |
| 1999 FY | 87.69 Thousand USD | 342.35% |
| 1998 Q4 | 19.82 Thousand USD | 0.0% |
| 1998 FY | 19.82 Thousand USD | 4.35% |
| 1997 FY | 18.99 Thousand USD | -61.8% |
| 1997 Q4 | 18.99 Thousand USD | 0.0% |
| 1996 FY | 49.73 Thousand USD | -41.9% |
| 1995 FY | 85.6 Thousand USD | -64.52% |
| 1994 FY | 241.24 Thousand USD | -36.85% |
| 1993 FY | 381.99 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 61.241% |
| BrainsWay Ltd. | 15.31 Million USD | -29.721% |
| Cerus Corporation | 144.3 Million USD | 86.234% |
| Envoy Medical, Inc. | 9.4 Million USD | -111.289% |
| electroCore, Inc. | 8.94 Million USD | -122.084% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -271.872% |
| IceCure Medical Ltd | 4.24 Million USD | -367.751% |
| Inogen, Inc. | 121.38 Million USD | 83.634% |
| OrthoPediatrics Corp. | 72.56 Million USD | 72.622% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 32.844% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -524.317% |
| MaxCyte, Inc. | 36.1 Million USD | 44.982% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -975.02% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -4571.124% |
| Orthofix Medical Inc. | 326.58 Million USD | 93.917% |
| PAVmed Inc | 57.13 Million USD | 65.232% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 21.983% |
| RxSight, Inc. | 22.18 Million USD | 10.468% |
| Sight Sciences, Inc. | 46.43 Million USD | 57.22% |
| SI-BONE, Inc. | 61.05 Million USD | 67.46% |
| TELA Bio, Inc. | 59.16 Million USD | 66.425% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 82.569% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -92.513% |
| Acutus Medical, Inc. | 54.83 Million USD | 63.775% |
| Talis Biomedical Corporation | 29.22 Million USD | 32.024% |
| Spectral AI, Inc. | 12.4 Million USD | -60.192% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 14.129% |
| CVRx, Inc. | 39.28 Million USD | 49.429% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -66.125% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -717.742% |
| Bioventus Inc. | 589.79 Million USD | 96.632% |
| Venus Concept Inc. | 107.1 Million USD | 81.452% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 61.548% |
| LivaNova PLC | 1.15 Billion USD | 98.275% |
| 908 Devices Inc. | 37.49 Million USD | 47.011% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 97.176% |
| Nemaura Medical Inc. | 26.37 Million USD | 24.688% |
| NeuroPace, Inc. | 86.99 Million USD | 77.165% |
| LENSAR, Inc. | 22.4 Million USD | 11.351% |
| Apyx Medical Corporation | 52.31 Million USD | 62.03% |
| Cutera, Inc. | 518.12 Million USD | 96.166% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 32.265% |
| BioSig Technologies, Inc. | 4.68 Million USD | -324.021% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 65.965% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 7.551% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.095% |
| Axonics, Inc. | 82.35 Million USD | 75.879% |
| Outset Medical, Inc. | 190.91 Million USD | 89.595% |
| IRIDEX Corporation | 24.91 Million USD | 20.264% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 83.975% |
| IRadimed Corporation | 20.73 Million USD | 4.198% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -1086.703% |
| INVO Bioscience, Inc. | 19.99 Million USD | 0.648% |
| Telesis Bio, Inc. | 40.87 Million USD | 51.397% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 51.299% |
| Varex Imaging Corporation | 668.6 Million USD | 97.029% |
| Quipt Home Medical Corp. | 136.29 Million USD | 85.424% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -456.142% |
| Pulmonx Corporation | 60.63 Million USD | 67.238% |
| Dynatronics Corporation | 11.78 Million USD | -68.635% |
| Modular Medical, Inc. | 2.27 Million USD | -774.358% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -388.814% |
| Semler Scientific, Inc. | 6.27 Million USD | -216.833% |
| InMode Ltd. | 75.91 Million USD | 73.832% |
| Bruker Corporation | 2.83 Billion USD | 99.3% |
| Cytosorbents Corporation | 29.98 Million USD | 33.75% |
| DexCom, Inc. | 4.19 Billion USD | 99.527% |
| Align Technology, Inc. | 2.45 Billion USD | 99.19% |
| Viveve Medical, Inc. | 10.84 Million USD | -83.142% |
| ZimVie Inc. | 795.85 Million USD | 97.504% |
| Movano Inc. | 5.97 Million USD | -232.642% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 81.009% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -4571.124% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -66.125% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 96.891% |
| Profound Medical Corp. | 12.66 Million USD | -56.842% |
| Insulet Corporation | 1.85 Billion USD | 98.929% |
| enVVeno Medical Corporation | 2.43 Million USD | -715.828% |
| Surmodics, Inc. | 65.82 Million USD | 69.82% |
| iCAD, Inc. | 8 Million USD | -148.287% |
| Nuwellis, Inc. | 6.78 Million USD | -193.0% |
| Biotricity, Inc. | 35.91 Million USD | 44.695% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 91.094% |
| Aethlon Medical, Inc. | 2.47 Million USD | -701.137% |
| InspireMD, Inc. | 8.14 Million USD | -143.987% |
| PAVmed Inc. | 57.13 Million USD | 65.232% |
| BIOLASE, Inc. | 35.34 Million USD | 43.8% |
| Beyond Air, Inc. | 29.77 Million USD | 33.282% |
| FONAR Corporation | 57.45 Million USD | 65.426% |
| AxoGen, Inc. | 101.16 Million USD | 80.363% |
| Vivani Medical, Inc. | 25.03 Million USD | 20.653% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 77.373% |
| Inari Medical, Inc. | 209.32 Million USD | 90.51% |
| UFP Technologies, Inc. | 118.04 Million USD | 83.171% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -56.538% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -808.834% |
| Tenon Medical, Inc. | 5.56 Million USD | -256.842% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1016.661% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -12.653% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.37% |
| Sintx Technologies, Inc. | 6.59 Million USD | -201.311% |
| NanoVibronix, Inc. | 2.68 Million USD | -639.591% |
| Quanterix Corporation | 78.08 Million USD | 74.559% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -456.142% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -306.661% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 98.098% |
| TransMedics Group, Inc. | 568.84 Million USD | 96.508% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -19.083% |
| NeuroMetrix, Inc. | 1.33 Million USD | -1390.139% |
| Hyperfine, Inc. | 9.8 Million USD | -102.708% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 92.062% |
| Biomerica, Inc. | 2.66 Million USD | -645.978% |
| Bone Biologics Corporation | 831.4 Thousand USD | -2289.386% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -906.514% |
| Silk Road Medical, Inc | 114.15 Million USD | 82.598% |